P512: Early proactive therapeutic drug monitoring with ustekinumab therapy in paediatric Crohn@E@s DiseaseECCO'24Year: 2024
Authors: Ricciuto, A.(1)*;McKay, H.(2);deBruyn, J.(3);Crowley, E.(4);Church, P.(2);Huynh, H.(5);Otley, A.(6);Shaikh, A.(2);El-Matary, W.(7);Wine, E.(5);Walters, T.(2);Griffiths, A.(2);
(1)The Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada;(2)The Hospital for Sick Children, Division of Gastroenterology Hepatology and Nutrition, Toronto, Canada;(3)University of Calgary, Division of Gastroenterology Hepatology and Nutrition, Calgary, Canada;(4)London Health Sciences Centre, Division of Gastroenterology Hepatology and Nutrition, London, Canada;(5)University of Alberta, Division of Gastroenterology Hepatology and Nutrition, Edmonton, Canada;(6)IWK Health Centre, Division of Gastroenterology Hepatology and Nutrition, Halifax, Canada;(7)University of Manitoba, Division fo Gastroenterology Hepatology and Nutrition, Winnipeg, Canada;
P513: Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort studyECCO'24Year: 2024
Authors: Kim, K.(1)*;Hong, S.N.(2);Kang, S.B.(3);Lee, K.M.(4);Koo, J.S.(5);Jung, Y.(6);Lee , B.J.(7);Yoon, H.(8);Kim, H.W.(9);Lim, Y.J.(10);Lee, H.S.(11);Lee, Y.J.(12);Lee, J.(13);Lee, C.K.(14);Shin, S.Y.(15);Moon, J.M.(15);Seo, J.(16);Choi , C.H.(17);
(1)Chung-Ang University Hospital, Department of gastroenterology, Seoul, Korea- Republic Of;(2)Samsung Medical Center- Sungkyunkwan University School of Medicine, Department of Medicine, Seoul, Korea- Republic Of;(3)Daejeon St. Mary’s Hospital- The Catholic University of Korea, Division of Gastroenterology- Department of Internal medicine-, Daejeon, Korea- Republic Of;(4)St. Vincent@E@s Hospital- College of Medicine- The Catholic University of Korea, Department of Internal Medicine, Suwon, Korea- Republic Of;(5)Korea University College of Medicine- Ansan- Korea, Department of Internal Medicine, Ansan, Korea- Republic Of;(6)Soonchunhyang University College of Medicine, Department of Internal Medicine, Cheonan, Korea- Republic Of;(7)Korea University College of Medicine, Department of Internal medicine, Seoul, Korea- Republic Of;(8)Seoul National University Bundang Hospital, Department of Internal Medicine, Seongnam, Korea- Republic Of;(9)Pusan National University Yangsan Hospital- Pusan National University College of Medicine, Department of Internal Medicine, Yangsan, Korea- Republic Of;(10)Dongguk University Ilsan Hospital, Department of Internal Medicine, Goyang, Korea- Republic Of;(11)Kyungpook National University School of Medicine, Department of Internal Medicine, Daegu, Korea- Republic Of;(12)Keimyung University School of Medicine, Department of Internal Medicine, Daegu, Korea- Republic Of;(13)Chosun University College of Medicine, Department of Internal Medicine, Gwangju, Korea- Republic Of;(14)Kyung Hee University School of Medicine, Department of internal medicine, Seoul, Korea- Republic Of;(15)Chung-Ang University Gwangmyeong Hospital, Department of internal medicine, Gwangmyeong, Korea- Republic Of;(16)Chung-Ang University Hospital, Department of internal medicine, Seoul, Korea- Republic Of;(17)Chung-Ang University Hospital, Department of internal mediciine, Seoul, Korea- Republic Of;
P514: Beyond the First Attempt: A Multi-Centre UK Analysis of Second JAK Inhibitor Use in Ulcerative ColitisECCO'24Year: 2024
Authors: Danso, Y.(1)*;Radia, C.(2);Kent, A.(2);Harrow, P.(3);Pavlidis, P.(2);Selinger, C.(4);Samaan, M.(5);Patel, K.(6);Kumar, R.(7);Fraser, A.(8);Allah-Ditta, M.(9);Pillay, L.(10);Bishara, M.(11);Campbell, R.(12);Patel, C.(5);Elford, A.(13);Dong , C.(14);Sethi-Arora , K.(15);Davis, E.(16);Hale, M.(17);Yeung, K.(18);Mehta, S.(6);Rees, F.(19);George, B.(20);Yeo, J.H.(3);Harvey, P.(21);Sawan , N.J.(22);Lees, C.(13);Walsh, A.(16);Rawcliffe, M.(17);Pollok, R.(6);Speight, A.(14);Al-zarrad, D.(18);Chhabra , P.(9);Raine, T.(10);Limdi, J.(15);Ahmad, T.(11);Toft, J.(3);Hussain, M.A.(7);Kok, K.(1);
(1)Barts and the London NHS Trust, Gastroenterology, London, United Kingdom;(2)Kings College NHS Foundation Trust, Gastroenterology, London, United Kingdom;(3)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(4)Leeds Teaching Hospitals NHS Trust., Gastroenterology, Leeds, United Kingdom;(5)Guy@E@s and St Thomas@E@ NHS Foundation Trust, Gastroenterology, London, United Kingdom;(6)St George’s Hospital, Gastroenterology, London, United Kingdom;(7)University Hospitals Birmingham NHS Foundation Trust, Gastroenterology, Birmingham, United Kingdom;(8)Bristol Royal Infirmary, Gastroenterology, Bristol, United Kingdom;(9)Calderdale and Huddersfield Foundation Trust, Gastroenterology, Huddersfield, United Kingdom;(10)Cambridge University Hospitals NHS Foundation Trust, Gastroenterology, Cambridge, United Kingdom;(11)Royal Devon University Hospitals NHS Foundation Trust, Gastroenterology, Exeter, United Kingdom;(12)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(13)NHS Lothian, Gastroenterology, Edinburgh, United Kingdom;(14)Royal Victoria Infirmary- Newcastle upon Tyne Hospitals, Gastroenterology, Newcastle, United Kingdom;(15)Northern Care Alliance NHS Foundation Trust, Gastroenterology, Manchester, United Kingdom;(16)Oxford University Hospitals, Gastroenterology, Oxford, United Kingdom;(17)Sheffield Teaching Hospitals NHS Foundation Trust., Gastroenterology, Sheffield, United Kingdom;(18)St Marks Hospital, Gastroenterology, London, United Kingdom;(19)University Hospitals Sussex, Gastroenterology, Sussex, United Kingdom;(20)Torbay and South Devon- Torbay Hospital, Gastroenterology, Torquay, United Kingdom;(21)The Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, United Kingdom;(22)Queen Elizabeth Hospital- Woolwich, Gastroenterology, London, United Kingdom;
P515: Exclusive enteral nutrition downstages complicated Crohn’s disease prior to surgical resection: A feasibility studyECCO'24Year: 2024
Authors: Zuk, D.(1)*;Jaksic, D.(1);Andersson, S.(2);Soop, M.(2);
(1)Ersta Hospital, Department of Surgery, Stockholm, Sweden;(2)Karolinska University Hospital, Department of Inflammatory Bowel Disease and Intestinal Failure Surgery, Stockholm, Sweden;
P516: Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes.ECCO'24Year: 2024
Authors: Iborra, M.(1)*;Caballol, B.(2);Garrido, A.(1);Huguet, J.M.(3);Mesonero, F.(4);Ponferrada, A.(5);Arias-García, L.(6);Boscá-Watts, M.M.(7);Fernández-Prada, S.J.(8);Brunet-Mas , E.(9);Gutierrez-Casbas, A.(10);Ordás, I.(2);Ruiz, L.(3);García de la Filia, I.(4);Escobar Ortiz, J.(5);Sicilia, B.(6);Ricart, E.(2);Nos, P.(1);
(1)La Fe University and Polytechnic Hospital, Department of Gastroenterology, Valencia, Spain;(2)Hospital Clínic Barcelona. IDIBAPS. CIBER-EHD., Unidad de enfermedad inflamatoria intestinal., Barcelona, Spain;(3)Hospital General Universitario de Valencia., Gastroenterology, Valencia, Spain;(4)Hospital Universitario Ramón y Cajal., Gastroenterology, Madrid, Spain;(5)Hospital Universitario Infanta Leonor., Gastroenterology, Madrid, Spain;(6)Hospital Universitario de Burgos, Gastroenterology, Burgos, Spain;(7)Hospital Clínico Universitario de Valencia, Gastroenterology, Valencia, Spain;(8)Hospital Rio Hortega, Gastroenterology, Valladolid, Spain;(9)Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí I3PT-CERCA and Departament de Medicina- Universitat Autònoma de Barcelona CIBERehd- Instituto de Salud Carlos III., Gastroenterology, Sabadell, Spain;(10)Hospital General Universitario de Alicante, Gastroenterology, Alicante, Spain;
P517: Endoscopic mucosal resection (EMR) in treatment of colitis associated neoplasia (CAN): a single-centre experience from Leuven, BelgiumECCO'24Year: 2024
Authors: Panic, N.(1)*;Vermeire, S.(2);Ingrid, D.(3);Joao, S.(2);Tarabar, D.(4);Bisschops, R.(2);
(1)University Clinic @D@Dr Dragisa Misovic-Dedinje@D@, Digestive Endoscopy Department, Beograd, Serbia;(2)Targid Ku Leuven, University Hospitals Leuven deot of Gastroenterology and Hepatology., Leuven, Belgium;(3)Targid Ku Leuven, University Hospitals Leuven deot of Gastroenterology and Hepatology, Leuven, Belgium;(4)University Clinic @D@Dr Dragisa Misovic-Dedinje@D@, Center for Inflammatory Bowel Disease, Belgrade, Serbia;
P518: Dietary and non-dietary predictors of treatment response to adalimumab in anti-TNFα-naïve adults with Crohn’s diseaseECCO'24Year: 2024
Authors: Jatkowska, A.(1)*;White, B.(1);Campbell, I.(1);Brownson, E.(2);Short, B.(1);Clowe, J.(1);Seenan, J.P.(2);Gaya, D.R.(3);Din, S.(4);Ho, G.T.(4);Robertson, E.(5);Mowat, C.(6);Milling, S.(7);MacDonald, J.(2);Gerasimidis, K.(1);
(1)University of Glasgow, Human Nutrition, Glasgow, United Kingdom;(2)Queen Elizabeth University Hospital, Department of Gastroenterology, Glasgow, United Kingdom;(3)Glasgow Royal Infirmary, Department of Gastroenterology, Glasgow, United Kingdom;(4)Western General Hospital, Department of Gastroenterology, Edinburgh, United Kingdom;(5)University Hospital Hairmyres, Department of Gastroenterology, Lanarkshire, United Kingdom;(6)Ninewells Hospital, Department of Gastroenterology, Dundee, United Kingdom;(7)University of Glasgow, School of Infection and Immunity, Glasgow, United Kingdom;
P519: Assessment of anal sphincter complex in pregnant patients with non-active perianal Crohns diseaseECCO'24Year: 2024
Authors: Bar-Gil Shitrit, A.(1)*;Mishael , T.(2);Reiss Mintz, H.(3);Goldenberg , R.(4);Freund, M.R.(5);Yellinek, S.(5);
(1)Shaare Zedek Medical Center, Department of Gastroenterology and Digestive Diseases, Jerusalem, Israel;(2)Shaare Zedek Medical Center, Gynecology, Jerusalem, Israel;(3)Mayanei Hayeshua Medical Center, Gastroenterology, Bnei Brak, Israel;(4)Shaare Zedek Medical Center, Gastroenterology, Jerusalem, Israel;(5)Shaare Zedek Medical Center, General Surgery, Jerusalem, Israel;
P520: Preferences towards treatment attributes among patients with Crohn’s disease and ulcerative colitis in Argentina, Australia, Brazil, Saudi Arabia and Taiwan: a discrete choice experimentECCO'24Year: 2024
Authors: Argollo, M.(1)*;An , Y.K.(2);Balderramo, D.(3);Nahla, A.(4);Kuo, C.J.(5);Fadeeva, O.(6);Uy, E.(6);
(1)Federal University of São Paulo, Department of Gastroenterology, São Paulo, Brazil;(2)Mater Hospital Brisbane, Inflammatory Bowel Disease, Brisbane, Australia;(3)Instituto Universitario de Ciencias Biomédicas de Córdoba, Servicio de Gastroenterología y Endoscopia Digestiva- Hospital Privado Universitario de Córdoba, Córdoba, Argentina;(4)King Saud University College of Medicine, Department of Medicine, Riyadh, Saudi Arabia;(5)Chang Gung Memorial Hospital, Department of Gastroenterology and Hepatology, Linkou, Taiwan;(6)Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals, Singapore, Singapore;
P521: Impact of pouch leaks on quality of life and symptoms in patients after ileal pouch-anal anastomosis surgeryECCO'24Year: 2024
Authors: Alipouriani, A.(1);Schabl, L.(1);hull, T.(1);Lipman, J.(1);Gorgun, E.(1);Liska, D.(1);valente, M.(1);Steele, S.R.(1);Holubar, S.(1)*;
(1)Cleveland Clinic Foundation- Cleveland- OH- USA, Department of Colon and Rectal Surgery, Cleveland, United States;
P522: Post hoc analysis reveals limited efficacy of induction therapy in ileum only Crohn´s diseaseECCO'24Year: 2024
Authors: Lundin, P.(1)*;Bock, D.(2);Harper, A.R.(3);Strömbeck, A.(1);Beaton, A.(4);Marks, D.J.B.(3);
(1)AstraZeneca Biopharmaceuticals R&D, Early R&I Clinical Development, Gothenburg, Sweden;(2)AstraZeneca Biopharmaceuticals R&D, Early Biometrics and Statistical Innovation, Gothenburg, Sweden;(3)AstraZeneca Biopharmaceuticals R&D, Early R&I Clinical Development, Cambridge, United Kingdom;(4)AstraZeneca Biopharmaceuticals R&D, Clinical Development Immunology, Cambridge, United Kingdom;
P523: The performance indicator of colonic intubation (PICI) in an Irish Inflammatory Bowel Disease (IBD) cohort.ECCO'24Year: 2024
Authors: Jones, F.(1)*;Lavelle, A.(2);McCarthy, F.(3);Patchett, S.(3);Morcos, A.(3);Moloney, M.(3);Cullen, G.(3);Slattery, E.(3);Leyden, J.(4);O@E@ Morain, C.(5);Egan, L.(5);Doherty, G.A.(6);
(1)St. Vincent@E@s University Hospital- Dublin, Gastroenterology, Dublin 3, Ireland;(2)University College Cork, Medicine, Cork, Ireland;(3)National Group Leads for Endoscopy, Health Service Executive, Dublin, Ireland;(4)HSE GI Endoscopy Programme, Health Service Executive, Dublin, Ireland;(5)National Gastroenterology Clinical Programme, Health Service Executive, Dublin, Ireland;(6)St. Vincent@E@s University Hospital, Gastroenterology, Dublin, Ireland;
P524: Etrasimod shows low risk of adverse events following concomitant use with opioids or antidepressants in patients with ulcerative colitisECCO'24Year: 2024
Authors: Afzali, A.(1)*;Regueiro, M.(2);Yarur, A.J.(3);Zabana, Y.(4);Ng, S.C.(5);Menon, S.S.(6);McDonnell, A.(7);Lazin, K.(8);Keating, M.(9);Bhattacharjee, A.(10);Branquinho, D.(9);Bananis, E.(11);Peyrin-Biroulet, L.(12,13,14,15,16,17);
(1)University of Cincinnati College of Medicine, Department of Internal Medicine, Cincinnati- OH, United States;(2)Cleveland Clinic, Department of Gastroenterology- Hepatology and Nutrition, Cleveland- OH, United States;(3)Cedars-Sinai Medical Center, Inflammatory Bowel Disease Center and Division of Gastroenterology and Hepatology, Los Angeles- CA, United States;(4)Hospital Universitari Mútua Terrassa and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Department of Gastroenterology, Madrid, Spain;(5)Institute of Digestive Disease- The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Hong Kong, China;(6)., Pfizer Inc, Groton- CT, United States;(7)., Pfizer Ltd, Sandwich, United Kingdom;(8)., Pfizer AG, Zürich, Switzerland;(9)., Pfizer Inc, New York- NY, United States;(10)., Pfizer Healthcare India Pvt. Ltd, Chennai, India;(11)., Pfizer Inc, Collegeville- PA, United States;(12)Nancy University Hospital, Department of Gastroenterology, F-54500 Vandœuvre-lès-Nancy, France;(13)Nancy University Hospital, Fédération Hospitalo-Universitaire-CURE, F-54500 Vandœuvre-lès-Nancy, France;(14)McGill University Health Centre, Division of Gastroenterology and Hepatology, Montreal- QC, Canada;(15)Paris IBD Center, Groupe Hospitalier privé Ambroise Paré - Hartmann, 92200 Neuilly sur Seine, France;(16)Nancy University Hospital, INFINY Institute, F-54500 Vandœuvre-lès-Nancy, France;(17)University of Lorraine, Inserm- NGERE, F-54000 Nancy, France;
P525: Utilisation of endoscopic ultrasonography for submucosal cushion measurement to determine eligibility for endoscopic submucosal dissection in ulcerative colitis-associated dysplasia: A case seriesECCO'24Year: 2024
Authors: Kim, K.(1)*;Hong, S.W.(2);Hwang, S.W.(2);Park, S.H.(2);Ye, B.D.(2);Byeon, J.S.(2);Myung, S.J.(2);Yang, S.K.(2);Yang, D.H.(2);
(1)Chung-Ang University Hospital, Department of Gastroenterology, Seoul, Korea- Republic Of;(2)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology, Seoul, Korea- Republic Of;
P526: Handsewn versus Stapled Ileocolic Anastomosis for Crohn@E@s: Comparable Outcomes Despite More Severe Disease Profile in the Handsewn GroupECCO'24Year: 2024
Authors: Alipouriani, A.(1);Uchino, T.(1);Erozkan, K.(1);Lipman , J.(1);Hull, T.(1);Steele, S.R.(1);Holubar, S.(1)*;
(1)Cleveland Clinic Foundation- Cleveland- OH- USA, Department of Colon and Rectal Surgery, Cleveland, United States;
P527: Factors associated with choice of treatment regimen after the induction period in patients with Ulcerative Colitis treated with vedolizumabECCO'24Year: 2024
Authors: Vuksanovic, S.(1)*;Spiric, J.(1);Toplicanin, A.(1);Nikolic, A.(1);Jovicic, I.(1);Djuranovic, S.(1,2);Popovic, D.(1,2);Dragasevic, S.(1,2);Sokic Milutinovic, A.(1,2);
(1)University Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia;(2)University of Belgrade, School of Medicine, Belgrade, Serbia;
P529: Assessing patient-perceived burden of disease in Crohn’s disease: a novel scoring approach in a real-world Australasian cohortECCO'24Year: 2024
Authors: Pipicella, J.L.(1,2,3)*;Gu, B.(1,4);Palmer, L.(5);Connor, S.J.(1,2,3,4);Wilson, W.(6,7);Andrews, J.M.(3,8,9);
(1)University of New South Wales, Medicine & Health South Western Sydney Clinical School, Sydney, Australia;(2)Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(3)Crohn@E@s Colitis Cure, CCCure, Pyrmont, Australia;(4)Liverpool Hospital, Gastroenterology and Hepatology, Liverpool, Australia;(5)The University of Adelaide, School of Public Health- Faculty of Health and Medical Sciences, Adelaide, Australia;(6)Lyell McEwin Hospital, Anaesthetics, Adelaide, Australia;(7)SA Health, Chief Medical Information Officer, Adelaide, Australia;(8)The University of Adelaide, Faculty of Health Sciences, Adelaide, Australia;(9)Central Adelaide Local Health Network, Gastroenterology, Adelaide, Australia;
P530: Early Intestinal Ultrasound changes to predict treatment response to anti-TNF therapy in paediatric Inflammatory Bowel Disease; a pilot studyECCO'24Year: 2024
Authors: Vos, H.(1)*;Gecse, K.(2);D@E@Haens, G.(2);Benninga, M.(1);Koot, B.(1);
(1)Amsterdam University Medical Centers, Paediatric Gastroenterology and Nutrition, Amsterdam, The Netherlands;(2)Amsterdam University Medical Centers, Gastroenterology and Hepatology, Amsterdam, The Netherlands;RAINBOW group
P531: Long-Term Evaluation of Intensified Ustekinumab in Crohn@E@s Disease: Real-Life ResultsECCO'24Year: 2024
Authors: Molina Arriero, G.(1)*;González Furelos, T.(2);Mauriz Barreiro, V.(1);Echarri Piudo, A.(1);
(1)Complejo Hospitalario Universitario de Ferrol, Gastroenterology, Ferrol, Spain;(2)Complejo Hospitalario Universitario de Ferrol, Pharmacology Department, Ferrol, Spain;
